GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,384.00p
   
  • Change Today:
    -66.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,108.34m
  • Volume: 3,008,030
  • Market Cap: £56,859m
  • RiskGrade: 129

Latest ShareCast News

GSK, AstraZeneca slide after FDA unveils new vaccine lead

By Abigail Townsend

Date: Wednesday 07 May 2025

(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.

GSK ShareCast News

GSK's Nucala delivers positive outcomes in publi... 01-May-2025 ShareCast
London close: Stocks finish higher as US economy... 30-Apr-2025 ShareCast
GSK confirms guidance after strong first quarter 30-Apr-2025 ShareCast
Two GSK vaccines get US CDC recommendations 17-Apr-2025 ShareCast
London close: Stocks fall as China retaliates to... 09-Apr-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 07-May-2025 07:00 RNS
Transaction in Own Shares 06-May-2025 07:00 RNS
Transaction in Own Shares 02-May-2025 07:00 RNS
Director/PDMR Shareholding 01-May-2025 15:30 RNS
Total Voting Rights 01-May-2025 15:00 RNS

GSK Newspaper Links

GSK and Pfizer settle patent dispute over RSV va... 06-May-2025 Times
GSK ‘well positioned’ to cope with US pharmaceut... 30-Apr-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,384.00p
Change Today -66.00p
% Change -4.55 %
52 Week High 1,812.50p
52 Week Low 1,264.00p
Volume 3,008,030
Shares Issued 4,108.34m
Market Cap £56,859m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.48% below the market average41.48% below the market average41.48% below the market average41.48% below the market average41.48% below the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Price Trend
6.80% above the market average6.80% above the market average6.80% above the market average6.80% above the market average6.80% above the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Income
70.11% above the market average70.11% above the market average70.11% above the market average70.11% above the market average70.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.41% below the market average42.41% below the market average42.41% below the market average42.41% below the market average42.41% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 07-May-2025

Time Volume / Share Price
12:44 1 @ 1,384.00p
12:44 0 @ 1,384.00p
12:44 1 @ 1,384.00p
12:44 0 @ 1,383.50p
12:44 280 @ 1,384.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page